(Q53657170)
Statements
Antileukemic effect of daclizumab in CD25 high-expressing leukemias and impact of tumor burden on antibody dosing. (English)
1 reference
Koon HB
1 reference
Severy P
1 reference
Hagg DS
1 reference
Butler K
1 reference
Hill T
1 reference
Jones AG
1 reference
Waldmann TA
1 reference
Junghans RP
1 reference
13 September 2005
1 reference
30
1 reference
2
1 reference
190-203
1 reference
Identifiers
1 reference